GlassScriptPhysician profile
Anne S Crouch
NPI 1154574689
$1,931.50
in general payments reported to CMS, 2019-2025
20 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $492 · 2022: $285 · 2023: $368 · 2024: $270 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994 · Travel and Lodging: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $993.91 |
| Travel and Lodging | $160.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $639.43 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Arthrex, INC. | $281.31 | 2025 | |
| Medtronic, INC. | $153.80 | 2021-2025 | Inceptiv |
| Biohaven Pharmaceutical Holding Company LTD. | $129.68 | 2022 | |
| Collegium Pharmaceutical, INC. | $93.90 | 2021-2024 | Belbuca, Nucynta |
| Abbvie INC. | $80.56 | 2021-2022 | |
| Virtus Pharmaceuticals LLC | $72.29 | 2021 | |
| Scilex Pharmaceuticals INC. | $71.94 | 2021-2022 | |
| Ibsa Pharma INC. | $67.19 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $64.11 | 2021 | |
| Forte Bio-Pharma LLC | $56.16 | 2021-2024 | Prolate, Nalocet |
| Nevro Corp. | $44.07 | 2024 | Senza |
| Abbott Laboratories | $40.06 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.61 | 2021-2023 | Relistor |
| Pfizer INC. | $26.49 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $17.08 | 2021 | |
| Valinor Pharma, LLC | $16.72 | 2023 | Movantik |
| Redhill Biopharma INC. | $14.70 | 2021 | |
| Baudax Bio INC. | $13.64 | 2021 | |
| Lilly USA, LLC | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Crouch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.